Papers: 25 Mar 2013 - 1 Apr 2013 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick A comparative study of CSF neurofilament light and heavy chain protein in MS. Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A, Leppert D, Giovannoni G, et al. Mult Scler. 2013 Mar 25. PMID: 23529999. Abstract Editors' Pick Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course. Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, et al. PLoS One. 2013; 8(3):e59707. Epub 2013 Mar 20. PMID: 23527256. Abstract Editors' Pick The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform. Jokubaitis VG, Spelman T, Lechner-Scott J, Barnett M, Shaw C, Vucic S, Liew D, Butzkueven H, Slee M, Slee M PLoS One. 2013; 8(3):e59694. Epub 2013 Mar 19. PMID: 23527252. Abstract Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis. Gately CM, Podbielska M, Counihan T, Hennessy M, Leahy T, Moran AP, Hogan EL, O'Keeffe J J Neuroimmunol. 2013 Mar 25. PMID: 23537888. Abstract Effect of stress on brain inflammation and multiple sclerosis. Karagkouni A, Alevizos M, Theoharides TC Autoimmun Rev. 2013 Mar 26. PMID: 23537508. Abstract Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient. Gorsane I, Aloui S, Letaif A, Hadhri R, Haouala F, Frih A, Dhia N B, Elmay M, Skhiri H Saudi J Kidney Dis Transpl. 2013 Mar-Apr; 24(2):309-14. PMID: 23538355. Abstract A population-based study of fall risk factors among people with multiple sclerosis in Stockholm county. Ytterberg C, Einarsson U, Holmqvist L W, Peterson E W J Rehabil Med. 2013 Mar 27. PMID: 23538713. Abstract Isolated and persistent cognitive dysfunction in a patient with acute disseminated encephalomyelitis. Adamec I, Klepac N, Kolenc D, Ozretić D, Habek M Cogn Behav Neurol. 2013 Mar; 26(1):30-5. PMID: 23538570. Abstract Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA Urology. 2013 Apr; 81(4):738-44. PMID: 23537757. Abstract Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica. Abaroa L, Quiroga S RA, Melamud L, Arakaki T, Garretto NS, Villa AM Arq Neuropsiquiatr. 2013 Mar 26. PMID: 23539090. Abstract Perception of muscular effort in multiple sclerosis. Kiselka A, Greisberger A, Heller M NeuroRehabilitation. 2013 Jan 1; 32(2):415-23. PMID: 23535807. Abstract Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS. Hobart J, Blight AR, Goodman A, Lynn F, Putzki N Neurology. 2013 Mar 27. PMID: 23535489. Abstract Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Uzawa A, Mori M, Sawai S, Masuda S, Muto M, Uchida T, Ito S, Nomura F, Kuwabara S Clin Chim Acta. 2013 Mar 25. PMID: 23535508. Abstract Subclinical Optic Neuritis in Neuromyelitis Optica. Aksoy D, Gokce E, Kurt S, Cevik B, Demir H D J Neuroophthalmol. 2013 Mar 26. PMID: 23535569. Abstract The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions. Hwang Y-I, Yoo W-G, An D-H, Heo H-J NeuroRehabilitation. 2013 Jan 1; 32(2):377-83. PMID: 23535802. Abstract Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis. Gabelic T, Skoric M K, Adamec I, Mayer D, Habek M Clin EEG Neurosci. 2013 Mar 26. PMID: 23536383. Abstract Radiolabeled anti-aquaporin-4 protein antibody imaging: a valuable method for determining neuromyelitis optica. Nemati R, Mehdizadeh S, Nabipour I, Amini A, Assadi M Nucl Med Commun. 2013 May; 34(5):413-6. PMID: 23535849. Abstract Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form. Askew RL, Kim J, Chung H, Cook KF, Johnson KL, Amtmann D Qual Life Res. 2013 Mar 29. Epub 2013 Mar 29. PMID: 23539469. Abstract Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil. Comini-Frota E R, Brum D G, Kaimen-Maciel D R, Fragoso Y D, Barreira A A, Donadi E A Clin Neurol Neurosurg. 2013 Mar 24. PMID: 23535450. Abstract Determinants of on-the-job-barriers in employed persons with multiple sclerosis: The role of disability severity and cognitive indices. Carrieri L, Sgaramella TM, Bortolon F, Stenta G, Fornaro L, Cracco A, Perini F, Soresi S Work. 2013 Mar 26. PMID: 23531588. Abstract Immunopathological characteristics of patients with bullous pemphigoid and neurological disease. Taghipour K, Chi C-C, Bhogal B, Groves RW, Venning V, Wojnarowska F J Eur Acad Dermatol Venereol. 2013 Mar 26. PMID: 23530989. Abstract Multiple Sclerosis: White and Gray Matter Damage Associated with Balance Deficit Detected at Static Posturography. Prosperini L, Sbardella E, Raz E, Cercignani M, Tona F, Bozzali M, Petsas N, Pozzilli C, Pantano P Radiology. 2013 Mar 26. PMID: 23533287. Abstract Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis. Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, Tang D, Zhang X Ophthalmology. 2013 Mar 23. PMID: 23531349. Abstract IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages. Ashbaugh JJ, Brambilla R, Karmally SA, Cabello C, Malek TR, Bethea JR J Immunol. 2013 Mar 25. PMID: 23530149. Abstract Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, et al. JAMA Neurol. 2013 Feb; 70(2):248-51. PMID: 23530268. Abstract [Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.] Belova AN, Shalenkov IV, Shakurova DN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):23-27. PMID: 23528590. Abstract [Evaluation of the autonomic regulation of the cardiac oxygen supply of measured physical activity in patients with remitting multiple sclerosis.] Belenko EA, Vorob'eva OV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):43-47. PMID: 23528593. Abstract [Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.] Zakharov AV, Khivintseva EV, Poverennova IE, Gindullina EA, Vlasov IV, Sineok EV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):28-31. PMID: 23528591. Abstract Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis. Hollingworth S, Walker K, Page A, Eadie M Mult Scler. 2013 Mar 25. PMID: 23530000. Abstract Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Freeman J, Walters R, Ingram W, Slade A, Hobart J, Zajicek J Mult Scler. 2013 Mar 25. PMID: 23530002. Abstract [Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.] Boĭko AN, Batysheva TT, Mel'nikov MV, Boĭko OV, Mugutdinova BT, Gorina TP, Ovcharov VV, Bykova OV, Popova NF, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):104-110. PMID: 23528602. Abstract [PET-patterns of cognitive impairment in patients with multiple sclerosis.] Shkil'niuk GG, Il'ves AG, Prakhova LN, Kataeva GV, Stoliarov ID Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):53-56. PMID: 23528594. Abstract Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain. Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N JAMA Neurol. 2013 Mar 25:1-6. PMID: 23529352. Abstract Serum uric acid level in patients with relapsing-remitting multiple sclerosis. Ashtari F, Bahar M, Aghaei M, Zahed A J Clin Neurosci. 2013 Mar 22. PMID: 23528410. Abstract [Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.] Alifirova VM, Musina NF Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):57-60. PMID: 23528595. Abstract Assessing possible selection bias in a national voluntary MS longitudinal study in Australia. Taylor BV, Palmer A, Simpson S, Lucas R, NZMSPS study group, Simmons RD, Mason D, Pearson J, Clarke G, Sabel C, et al. Mult Scler. 2013 Mar 25. PMID: 23530001. Abstract [Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.] Karpov MI, Sokolov AA, Bisaga GN, Mikhal'tsova EN, Odinak MM Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):100-103. PMID: 23528601. Abstract Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ JAMA Neurol. 2013 Mar 25:1-5. PMID: 23529376. Abstract Characterization of In Vitro Expanded Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Experimental Autoimmune Encephalomyelitis Mice. Zacharaki D, Lagoudaki R, Touloumi O, Kotta K, Voultsiadou A, Poulatsidou K-N, Lourbopoulos A, Hadjigeorgiou G, Dardiotis E, Karacostas D, et al. J Mol Neurosci. 2013 Mar 27. Epub 2013 Mar 27. PMID: 23532769. Abstract [The effect of genetic factors on the phenotypic expression of multiple sclerosis.] Korobko DS, Malkova NA, Bulatova EV, Babenko LA, Sazonov DV, Sokolova EA, Filipenko ML Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):10-16. PMID: 23528589. Abstract [The first results of a combined all-Russian study on clinical genetics of multiple sclerosis.] Sokolova EA, Malkova NA, Korobko DS, Rozhdestvenskiĭ AS, Kakulia AV, Khanokh EV, Delov RA, Platonov FA, Popova TE, Aref'eva EG, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):6-9. PMID: 23528588. Abstract [The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.] Kotov SV, Fedorova SI, Iakushina TI, Lizhdvoĭ IV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):74-78. PMID: 23528598. Abstract Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature. Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED Ann Pharmacother. 2013 Apr; 47(4):537-42. Epub 2013 Mar 27. PMID: 23535814. Abstract [Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.] Iakushina TI, Eliseev IV, Kotov SV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):83-86. PMID: 23528600. Abstract [Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results).] Iakushina TI, Lizhdvoĭ IV, Vasilenko IA, Andriukhina OM, Kotov SV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):61-65. PMID: 23528596. Abstract [Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"] Popova EV, Brylev LV, Davydovskaia MV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):79-82. PMID: 23528599. Abstract [Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.] Vlasov IV, Dolgikh GT, Dolgikh TA, Kurapov MA, Nilov AI, Tarasova SV, Churakov MV, Khivintseva EV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):66-73. PMID: 23528597. Abstract The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range. Brodie AM, Lucas R, Harrison SL, van der Mei I, Armstrong B, Kricker A, Mason RS, McMichael AJ, Nowak M, Whiteman DC, et al. Am J Epidemiol. 2013 Mar 22. PMID: 23524036. Abstract Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients. Fekih Mrissa N, Mrad M, Klai S, Zaouali J, Sayeh A, Mazigh C, Nsiri B, Machgoul S, Gritli N, Mrissa R Clin Neurol Neurosurg. 2013 Mar 21. PMID: 23523621. Abstract Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis? Nat Rev Neurol. 2013 Apr; 9(4):184. Epub 2013 Mar 26. PMID: 23528541. Abstract Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation. Wakao H, Yoshikiyo K, Koshimizu U, Furukawa T, Enomoto K, Matsunaga T, Tanaka T, Yasutomi Y, Yamada T, Minakami H, et al. Cell Stem Cell. 2013 Mar 19. PMID: 23523177. Abstract The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Stangel M, Fredrikson S, Meinl E, Petzold A, Stüve O, Tumani H Nat Rev Neurol. 2013 May; 9(5):267-76. Epub 2013 Mar 26. PMID: 23528543. Abstract Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris. Martin-Eauclaire M-F, Céard B, Belghazi M, Lebrun R, Bougis PE Toxicon. 2013 Mar 21. PMID: 23523531. Abstract Idiopathic inflammatory demyelinating diseases of the brainstem. Rovira A, Sastre-Garriga J, Auger C, Rovira A Semin Ultrasound CT MR. 2013 Apr; 34(2):123-30. PMID: 23522777. Abstract Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD Clin Ther. 2013 Mar 20. PMID: 23522658. Abstract Movement disorders in multiple sclerosis and other demyelinating diseases. Mehanna R, Jankovic J J Neurol Sci. 2013 Mar 19. PMID: 23522528. Abstract Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study. Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Maria Malagoni A, et al. J Vasc Interv Radiol. 2013 Mar 20. PMID: 23523158. Abstract Physical fitness, walking performance, and gait in multiple sclerosis. Sandroff BM, Sosnoff JJ, Motl RW J Neurol Sci. 2013 Mar 20. PMID: 23522499. Abstract Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. Xu M-X, Tan B-C, Zhou W, Wei T, Lai W-H, Tan J-W, Dong J-H CNS Neurosci Ther. 2013 Apr; 19(4):235-43. PMID: 23521911. Abstract Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE. Farias AS, Spagnol GS, Bordeaux-Rego P, Oliveira COF, Fontana A GM, de Paula RFO, Santos MPA, Pradella F, Moraes AS, Oliveira EC, et al. CNS Neurosci Ther. 2013 Apr; 19(4):269-77. PMID: 23521914. Abstract Discovery of peptoid ligands for anti-aquaporin 4 antibodies. Raveendra BL, Wu H, Baccala R, Reddy MM, Schilke J, Bennett JL, Theofilopoulos AN, Kodadek T Chem Biol. 2013 Mar 21; 20(3):351-9. PMID: 23521793. Abstract Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases. Gredler V, Mader S, Schanda K, Hegen H, Di Pauli F, Kuenz B, Deisenhammer F, Berger T, Reindl M, Lutterotti A J Neurol Sci. 2013 Mar 20. PMID: 23522498. Abstract Autoimmune diseases and reproductive aging. Bove R Clin Immunol. 2013 Feb 28. PMID: 23522436. Abstract Brain atrophy and lesion load predict long term disability in multiple sclerosis. Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani M P, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, et al. J Neurol Neurosurg Psychiatry. 2013 Mar 23. PMID: 23524331. Abstract Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens. Farooq SM, Ashour HM CNS Neurosci Ther. 2013 Mar 22. PMID: 23522052. Abstract Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis. Unger MM, Oertel WH, Tackenberg B Neuro Endocrinol Lett. 2013; 34(1):14-7. PMID: 23524619. Abstract TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis. Attfield KE, Fugger L J Immunol. 2013 Apr 1; 190(7):3015-7. PMID: 23526826. Abstract Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism. Dibbert S, Clement B, Skak-Nielsen T, Mrowietz U, Rostami-Yazdi M Arch Dermatol Res. 2013 Mar 25. Epub 2013 Mar 25. PMID: 23525570. Abstract European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil. Brum D G, Luizon M R, Santos A C, Lana-Peixoto M A, Rocha C F, Brito M L, de Oliveira E M L, Bichuetti D B, Gabbai A A, Diniz D S, et al. PLoS One. 2013; 8(3):e58925. Epub 2013 Mar 20. PMID: 23527051. Abstract Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X, Qin X Int J Mol Med. 2013 May; 31(5):1209-21. Epub 2013 Mar 15. PMID: 23525227. Abstract Adapted exercise interventions for persons with progressive multiple sclerosis. Pilutti LA Appl Physiol Nutr Metab. 2013 Mar; 38(3):357. Epub 2013 Mar 15. PMID: 23537031. Abstract Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication. Gustafsson RKL, Engdahl EE, Hammarfjord O, Adikari SB, Lourda M, Klingström J, Svensson M, Fogdell-Hahn A PLoS One. 2013; 8(3):e58122. Epub 2013 Mar 05. PMID: 23526966. Abstract Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. Carter CJ J Pathog. 2013; 2013:965046. Epub 2013 Mar 04. PMID: 23533776. Abstract Gait variability and multiple sclerosis. Socie MJ, Sosnoff JJ Mult Scler Int. 2013; 2013:645197. Epub 2013 Mar 03. PMID: 23533759. Abstract Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Baumstarck K, Boyer L, Boucekine M, Michel P, Pelletier J, Auquier P Mult Scler Int. 2013; 2013:524894. Epub 2013 Feb 28. PMID: 23533758. Abstract
Editors' Pick A comparative study of CSF neurofilament light and heavy chain protein in MS. Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A, Leppert D, Giovannoni G, et al. Mult Scler. 2013 Mar 25. PMID: 23529999. Abstract
Editors' Pick Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course. Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, et al. PLoS One. 2013; 8(3):e59707. Epub 2013 Mar 20. PMID: 23527256. Abstract
Editors' Pick The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform. Jokubaitis VG, Spelman T, Lechner-Scott J, Barnett M, Shaw C, Vucic S, Liew D, Butzkueven H, Slee M, Slee M PLoS One. 2013; 8(3):e59694. Epub 2013 Mar 19. PMID: 23527252. Abstract
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis. Gately CM, Podbielska M, Counihan T, Hennessy M, Leahy T, Moran AP, Hogan EL, O'Keeffe J J Neuroimmunol. 2013 Mar 25. PMID: 23537888. Abstract
Effect of stress on brain inflammation and multiple sclerosis. Karagkouni A, Alevizos M, Theoharides TC Autoimmun Rev. 2013 Mar 26. PMID: 23537508. Abstract
Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient. Gorsane I, Aloui S, Letaif A, Hadhri R, Haouala F, Frih A, Dhia N B, Elmay M, Skhiri H Saudi J Kidney Dis Transpl. 2013 Mar-Apr; 24(2):309-14. PMID: 23538355. Abstract
A population-based study of fall risk factors among people with multiple sclerosis in Stockholm county. Ytterberg C, Einarsson U, Holmqvist L W, Peterson E W J Rehabil Med. 2013 Mar 27. PMID: 23538713. Abstract
Isolated and persistent cognitive dysfunction in a patient with acute disseminated encephalomyelitis. Adamec I, Klepac N, Kolenc D, Ozretić D, Habek M Cogn Behav Neurol. 2013 Mar; 26(1):30-5. PMID: 23538570. Abstract
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA Urology. 2013 Apr; 81(4):738-44. PMID: 23537757. Abstract
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica. Abaroa L, Quiroga S RA, Melamud L, Arakaki T, Garretto NS, Villa AM Arq Neuropsiquiatr. 2013 Mar 26. PMID: 23539090. Abstract
Perception of muscular effort in multiple sclerosis. Kiselka A, Greisberger A, Heller M NeuroRehabilitation. 2013 Jan 1; 32(2):415-23. PMID: 23535807. Abstract
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS. Hobart J, Blight AR, Goodman A, Lynn F, Putzki N Neurology. 2013 Mar 27. PMID: 23535489. Abstract
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Uzawa A, Mori M, Sawai S, Masuda S, Muto M, Uchida T, Ito S, Nomura F, Kuwabara S Clin Chim Acta. 2013 Mar 25. PMID: 23535508. Abstract
Subclinical Optic Neuritis in Neuromyelitis Optica. Aksoy D, Gokce E, Kurt S, Cevik B, Demir H D J Neuroophthalmol. 2013 Mar 26. PMID: 23535569. Abstract
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions. Hwang Y-I, Yoo W-G, An D-H, Heo H-J NeuroRehabilitation. 2013 Jan 1; 32(2):377-83. PMID: 23535802. Abstract
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis. Gabelic T, Skoric M K, Adamec I, Mayer D, Habek M Clin EEG Neurosci. 2013 Mar 26. PMID: 23536383. Abstract
Radiolabeled anti-aquaporin-4 protein antibody imaging: a valuable method for determining neuromyelitis optica. Nemati R, Mehdizadeh S, Nabipour I, Amini A, Assadi M Nucl Med Commun. 2013 May; 34(5):413-6. PMID: 23535849. Abstract
Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form. Askew RL, Kim J, Chung H, Cook KF, Johnson KL, Amtmann D Qual Life Res. 2013 Mar 29. Epub 2013 Mar 29. PMID: 23539469. Abstract
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil. Comini-Frota E R, Brum D G, Kaimen-Maciel D R, Fragoso Y D, Barreira A A, Donadi E A Clin Neurol Neurosurg. 2013 Mar 24. PMID: 23535450. Abstract
Determinants of on-the-job-barriers in employed persons with multiple sclerosis: The role of disability severity and cognitive indices. Carrieri L, Sgaramella TM, Bortolon F, Stenta G, Fornaro L, Cracco A, Perini F, Soresi S Work. 2013 Mar 26. PMID: 23531588. Abstract
Immunopathological characteristics of patients with bullous pemphigoid and neurological disease. Taghipour K, Chi C-C, Bhogal B, Groves RW, Venning V, Wojnarowska F J Eur Acad Dermatol Venereol. 2013 Mar 26. PMID: 23530989. Abstract
Multiple Sclerosis: White and Gray Matter Damage Associated with Balance Deficit Detected at Static Posturography. Prosperini L, Sbardella E, Raz E, Cercignani M, Tona F, Bozzali M, Petsas N, Pozzilli C, Pantano P Radiology. 2013 Mar 26. PMID: 23533287. Abstract
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis. Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, Tang D, Zhang X Ophthalmology. 2013 Mar 23. PMID: 23531349. Abstract
IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages. Ashbaugh JJ, Brambilla R, Karmally SA, Cabello C, Malek TR, Bethea JR J Immunol. 2013 Mar 25. PMID: 23530149. Abstract
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, et al. JAMA Neurol. 2013 Feb; 70(2):248-51. PMID: 23530268. Abstract
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.] Belova AN, Shalenkov IV, Shakurova DN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):23-27. PMID: 23528590. Abstract
[Evaluation of the autonomic regulation of the cardiac oxygen supply of measured physical activity in patients with remitting multiple sclerosis.] Belenko EA, Vorob'eva OV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):43-47. PMID: 23528593. Abstract
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.] Zakharov AV, Khivintseva EV, Poverennova IE, Gindullina EA, Vlasov IV, Sineok EV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):28-31. PMID: 23528591. Abstract
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis. Hollingworth S, Walker K, Page A, Eadie M Mult Scler. 2013 Mar 25. PMID: 23530000. Abstract
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Freeman J, Walters R, Ingram W, Slade A, Hobart J, Zajicek J Mult Scler. 2013 Mar 25. PMID: 23530002. Abstract
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.] Boĭko AN, Batysheva TT, Mel'nikov MV, Boĭko OV, Mugutdinova BT, Gorina TP, Ovcharov VV, Bykova OV, Popova NF, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):104-110. PMID: 23528602. Abstract
[PET-patterns of cognitive impairment in patients with multiple sclerosis.] Shkil'niuk GG, Il'ves AG, Prakhova LN, Kataeva GV, Stoliarov ID Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):53-56. PMID: 23528594. Abstract
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain. Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N JAMA Neurol. 2013 Mar 25:1-6. PMID: 23529352. Abstract
Serum uric acid level in patients with relapsing-remitting multiple sclerosis. Ashtari F, Bahar M, Aghaei M, Zahed A J Clin Neurosci. 2013 Mar 22. PMID: 23528410. Abstract
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.] Alifirova VM, Musina NF Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):57-60. PMID: 23528595. Abstract
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia. Taylor BV, Palmer A, Simpson S, Lucas R, NZMSPS study group, Simmons RD, Mason D, Pearson J, Clarke G, Sabel C, et al. Mult Scler. 2013 Mar 25. PMID: 23530001. Abstract
[Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.] Karpov MI, Sokolov AA, Bisaga GN, Mikhal'tsova EN, Odinak MM Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):100-103. PMID: 23528601. Abstract
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ JAMA Neurol. 2013 Mar 25:1-5. PMID: 23529376. Abstract
Characterization of In Vitro Expanded Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Experimental Autoimmune Encephalomyelitis Mice. Zacharaki D, Lagoudaki R, Touloumi O, Kotta K, Voultsiadou A, Poulatsidou K-N, Lourbopoulos A, Hadjigeorgiou G, Dardiotis E, Karacostas D, et al. J Mol Neurosci. 2013 Mar 27. Epub 2013 Mar 27. PMID: 23532769. Abstract
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.] Korobko DS, Malkova NA, Bulatova EV, Babenko LA, Sazonov DV, Sokolova EA, Filipenko ML Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):10-16. PMID: 23528589. Abstract
[The first results of a combined all-Russian study on clinical genetics of multiple sclerosis.] Sokolova EA, Malkova NA, Korobko DS, Rozhdestvenskiĭ AS, Kakulia AV, Khanokh EV, Delov RA, Platonov FA, Popova TE, Aref'eva EG, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):6-9. PMID: 23528588. Abstract
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.] Kotov SV, Fedorova SI, Iakushina TI, Lizhdvoĭ IV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):74-78. PMID: 23528598. Abstract
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature. Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED Ann Pharmacother. 2013 Apr; 47(4):537-42. Epub 2013 Mar 27. PMID: 23535814. Abstract
[Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.] Iakushina TI, Eliseev IV, Kotov SV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):83-86. PMID: 23528600. Abstract
[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results).] Iakushina TI, Lizhdvoĭ IV, Vasilenko IA, Andriukhina OM, Kotov SV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):61-65. PMID: 23528596. Abstract
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"] Popova EV, Brylev LV, Davydovskaia MV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):79-82. PMID: 23528599. Abstract
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.] Vlasov IV, Dolgikh GT, Dolgikh TA, Kurapov MA, Nilov AI, Tarasova SV, Churakov MV, Khivintseva EV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Vypusk 2 Rasseiannyi skleroz):66-73. PMID: 23528597. Abstract
The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range. Brodie AM, Lucas R, Harrison SL, van der Mei I, Armstrong B, Kricker A, Mason RS, McMichael AJ, Nowak M, Whiteman DC, et al. Am J Epidemiol. 2013 Mar 22. PMID: 23524036. Abstract
Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients. Fekih Mrissa N, Mrad M, Klai S, Zaouali J, Sayeh A, Mazigh C, Nsiri B, Machgoul S, Gritli N, Mrissa R Clin Neurol Neurosurg. 2013 Mar 21. PMID: 23523621. Abstract
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis? Nat Rev Neurol. 2013 Apr; 9(4):184. Epub 2013 Mar 26. PMID: 23528541. Abstract
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation. Wakao H, Yoshikiyo K, Koshimizu U, Furukawa T, Enomoto K, Matsunaga T, Tanaka T, Yasutomi Y, Yamada T, Minakami H, et al. Cell Stem Cell. 2013 Mar 19. PMID: 23523177. Abstract
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Stangel M, Fredrikson S, Meinl E, Petzold A, Stüve O, Tumani H Nat Rev Neurol. 2013 May; 9(5):267-76. Epub 2013 Mar 26. PMID: 23528543. Abstract
Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris. Martin-Eauclaire M-F, Céard B, Belghazi M, Lebrun R, Bougis PE Toxicon. 2013 Mar 21. PMID: 23523531. Abstract
Idiopathic inflammatory demyelinating diseases of the brainstem. Rovira A, Sastre-Garriga J, Auger C, Rovira A Semin Ultrasound CT MR. 2013 Apr; 34(2):123-30. PMID: 23522777. Abstract
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD Clin Ther. 2013 Mar 20. PMID: 23522658. Abstract
Movement disorders in multiple sclerosis and other demyelinating diseases. Mehanna R, Jankovic J J Neurol Sci. 2013 Mar 19. PMID: 23522528. Abstract
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study. Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Maria Malagoni A, et al. J Vasc Interv Radiol. 2013 Mar 20. PMID: 23523158. Abstract
Physical fitness, walking performance, and gait in multiple sclerosis. Sandroff BM, Sosnoff JJ, Motl RW J Neurol Sci. 2013 Mar 20. PMID: 23522499. Abstract
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. Xu M-X, Tan B-C, Zhou W, Wei T, Lai W-H, Tan J-W, Dong J-H CNS Neurosci Ther. 2013 Apr; 19(4):235-43. PMID: 23521911. Abstract
Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE. Farias AS, Spagnol GS, Bordeaux-Rego P, Oliveira COF, Fontana A GM, de Paula RFO, Santos MPA, Pradella F, Moraes AS, Oliveira EC, et al. CNS Neurosci Ther. 2013 Apr; 19(4):269-77. PMID: 23521914. Abstract
Discovery of peptoid ligands for anti-aquaporin 4 antibodies. Raveendra BL, Wu H, Baccala R, Reddy MM, Schilke J, Bennett JL, Theofilopoulos AN, Kodadek T Chem Biol. 2013 Mar 21; 20(3):351-9. PMID: 23521793. Abstract
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases. Gredler V, Mader S, Schanda K, Hegen H, Di Pauli F, Kuenz B, Deisenhammer F, Berger T, Reindl M, Lutterotti A J Neurol Sci. 2013 Mar 20. PMID: 23522498. Abstract
Autoimmune diseases and reproductive aging. Bove R Clin Immunol. 2013 Feb 28. PMID: 23522436. Abstract
Brain atrophy and lesion load predict long term disability in multiple sclerosis. Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani M P, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, et al. J Neurol Neurosurg Psychiatry. 2013 Mar 23. PMID: 23524331. Abstract
Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens. Farooq SM, Ashour HM CNS Neurosci Ther. 2013 Mar 22. PMID: 23522052. Abstract
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis. Unger MM, Oertel WH, Tackenberg B Neuro Endocrinol Lett. 2013; 34(1):14-7. PMID: 23524619. Abstract
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis. Attfield KE, Fugger L J Immunol. 2013 Apr 1; 190(7):3015-7. PMID: 23526826. Abstract
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism. Dibbert S, Clement B, Skak-Nielsen T, Mrowietz U, Rostami-Yazdi M Arch Dermatol Res. 2013 Mar 25. Epub 2013 Mar 25. PMID: 23525570. Abstract
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil. Brum D G, Luizon M R, Santos A C, Lana-Peixoto M A, Rocha C F, Brito M L, de Oliveira E M L, Bichuetti D B, Gabbai A A, Diniz D S, et al. PLoS One. 2013; 8(3):e58925. Epub 2013 Mar 20. PMID: 23527051. Abstract
Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X, Qin X Int J Mol Med. 2013 May; 31(5):1209-21. Epub 2013 Mar 15. PMID: 23525227. Abstract
Adapted exercise interventions for persons with progressive multiple sclerosis. Pilutti LA Appl Physiol Nutr Metab. 2013 Mar; 38(3):357. Epub 2013 Mar 15. PMID: 23537031. Abstract
Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication. Gustafsson RKL, Engdahl EE, Hammarfjord O, Adikari SB, Lourda M, Klingström J, Svensson M, Fogdell-Hahn A PLoS One. 2013; 8(3):e58122. Epub 2013 Mar 05. PMID: 23526966. Abstract
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. Carter CJ J Pathog. 2013; 2013:965046. Epub 2013 Mar 04. PMID: 23533776. Abstract
Gait variability and multiple sclerosis. Socie MJ, Sosnoff JJ Mult Scler Int. 2013; 2013:645197. Epub 2013 Mar 03. PMID: 23533759. Abstract
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Baumstarck K, Boyer L, Boucekine M, Michel P, Pelletier J, Auquier P Mult Scler Int. 2013; 2013:524894. Epub 2013 Feb 28. PMID: 23533758. Abstract